{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:21:43Z","timestamp":1760955703401,"version":"3.41.0"},"reference-count":43,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7046","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T07:41:22Z","timestamp":1500622882000},"page":"4151-4158","source":"Crossref","is-referenced-by-count":4,"title":["Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma"],"prefix":"10.3892","volume":"16","author":[{"given":"Luo-Qin","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Kun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Lan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"key":"key20180108003344_b1-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: Defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"key20180108003344_b2-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0031-6997(24)01381-4","article-title":"Inflammatory mediators of asthma: An update","volume":"50","author":"Barnes","year":"1999","journal-title":"Pharmacol Rev"},{"key":"key20180108003344_b3-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"B12","DOI":"10.1038\/35037009","article-title":"The role of allergy in the development of asthma","volume":"402","author":"Holt","year":"1999","journal-title":"Nature"},{"key":"key20180108003344_b4-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/mi.2012.74","article-title":"The alveolar macrophages in asthma: A double-edged sword","volume":"5","author":"Balhara","year":"2012","journal-title":"Mucosal Immunol"},{"key":"key20180108003344_b5-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1465-9921-12-47","article-title":"A new pathway of glucocorticoid action for asthma treatment through the regulation of PTEN expression","volume":"12","author":"Ni","year":"2011","journal-title":"Respir Res"},{"key":"key20180108003344_b6-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0163-7258(02)00233-4","article-title":"Anti-allergic therapies: Effects on eosinophil progenitors","volume":"95","author":"Baatjes","year":"2002","journal-title":"Pharmacol Ther"},{"key":"key20180108003344_b7-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.163.3.1545","article-title":"Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia","volume":"163","author":"Jahnsen","year":"1999","journal-title":"J Immunol"},{"key":"key20180108003344_b8-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm.2754","article-title":"Therapies for allergic inflammation: Refining strategies to induce tolerance","volume":"18","author":"Akdis","year":"2012","journal-title":"Nat Med"},{"key":"key20180108003344_b9-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.rmed.2005.11.020","article-title":"Systemic side effects of inhaled corticosteroids in patients with asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir Med"},{"key":"key20180108003344_b10-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/039463200902200201","article-title":"Pidotimod: A reappraisal","volume":"22","author":"Riboldi","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20180108003344_b11-mmr-16-04-4151","first-page":"363","article-title":"Pidotimod may prevent recurrent respiratory infections in children","volume":"66","author":"Licari","year":"2014","journal-title":"Minerva Pediatr"},{"key":"key20180108003344_b12-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/039463201402700311","article-title":"Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: A multicentre study","volume":"27","author":"Namazova-Baranova","year":"1900","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20180108003344_b13-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1824-7288-39-29","article-title":"Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression","volume":"39","author":"Carta","year":"2013","journal-title":"Ital J Pediatr"},{"key":"key20180108003344_b14-mmr-16-04-4151","first-page":"1421","article-title":"Immunomodulating activity of pidotimod","volume":"44","author":"Migliorati","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"key20180108003344_b15-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4161\/hv.20579","article-title":"The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: Pidotimod(PTD)","volume":"8","author":"Hu","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key20180108003344_b16-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00726-014-1676-4","article-title":"The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function","volume":"46","author":"Hu","year":"2014","journal-title":"Amino Acids"},{"key":"key20180108003344_b17-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.170.6.3296","article-title":"A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse","volume":"170","author":"Shen","year":"2003","journal-title":"J Immunol"},{"key":"key20180108003344_b18-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20051680","article-title":"Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma","volume":"203","author":"Tong","year":"2006","journal-title":"J Exp Med"},{"key":"key20180108003344_b19-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20061134","article-title":"Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation","volume":"204","author":"Bandukwala","year":"2007","journal-title":"J Exp Med"},{"key":"key20180108003344_b20-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/rr39","article-title":"Th2 cytokines and asthma: An introduction","volume":"2","author":"Barnes","year":"2001","journal-title":"Respir Res"},{"key":"key20180108003344_b21-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3892\/etm.2014.1580","article-title":"FIZZ1 promotes airway remodeling through the PI3K\/Akt signaling pathway in asthma","volume":"7","author":"Wang","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20180108003344_b22-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/FPC.0b013e328336c7fd","article-title":"Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response","volume":"20","author":"Vonk","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"key20180108003344_b23-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ACI.0000000000000084","article-title":"Allergy immunotherapy: What is the evidence for cost saving?","volume":"14","author":"Hankin","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"key20180108003344_b24-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/msj.20294","article-title":"Treatment of Asthma and Food Allergy With Herbal Interventions From Traditional Chinese Medicine","volume":"78","author":"Li","year":"2011","journal-title":"Mt Sinai J Med"},{"key":"key20180108003344_b25-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/dmm.000323","article-title":"Mouse models of allergic asthma: Acute and chronic allergen challenge","volume":"1","author":"Nials","year":"2008","journal-title":"Dis Models Mech"},{"key":"key20180108003344_b26-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1067\/mpd.2000.103353","article-title":"A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children","volume":"136","author":"Gries","year":"2000","journal-title":"J Pediatr"},{"key":"key20180108003344_b27-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000097024","article-title":"Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model","volume":"142","author":"Zhao","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"key20180108003344_b28-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01844196","article-title":"An overview of glucocorticoid anti-inflammatory actions","volume":"45","author":"Schleimer","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"key20180108003344_b29-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1081\/JAS-120026085","article-title":"Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children","volume":"41","author":"Gourgiotis","year":"2004","journal-title":"J Asthma"},{"key":"key20180108003344_b30-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.4049\/jimmunol.162.10.6178","article-title":"Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils","volume":"162","author":"Cohn","year":"1999","journal-title":"J Immunol"},{"key":"key20180108003344_b31-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.4049\/jimmunol.169.11.6482","article-title":"The role of IL-13 in established allergic airway disease","volume":"169","author":"Taube","year":"2002","journal-title":"J Immunol"},{"key":"key20180108003344_b32-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1093\/emboj\/19.15.4046","article-title":"FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family","volume":"19","author":"Holcomb","year":"2000","journal-title":"EMBO J"},{"key":"key20180108003344_b33-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/02770900802126941","article-title":"FIZZ1 plays a crucial role in early stage airway remodeling of OVA-induced asthma","volume":"45","author":"Dong","year":"2008","journal-title":"J Asthma"},{"key":"key20180108003344_b34-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1526054202002610","article-title":"Does remodelling of the airway wall precede asthma?","volume":"3","author":"Baldwin","year":"2002","journal-title":"Paediatr Respir Rev"},{"key":"key20180108003344_b35-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.RES.0000073999.07698.33","article-title":"FIZZ1\/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties","volume":"92","author":"Teng","year":"2003","journal-title":"Circ Res"},{"key":"key20180108003344_b36-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/pr800685h","article-title":"Oxidative stress and asthma: Proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid","volume":"8","author":"Zhang","year":"2009","journal-title":"J Proteome Res"},{"key":"key20180108003344_b37-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/eji.201445419","article-title":"Arginase 1 activity worsens lung-protective immunity against Streptococcus pneumoniae infection","volume":"45","author":"Knippenberg","year":"2015","journal-title":"Eur J Immunol"},{"key":"key20180108003344_b38-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1476-5381.2009.00374.x","article-title":"Arginase: A key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives","volume":"158","author":"Maarsingh","year":"2009","journal-title":"Br J Pharmacol"},{"key":"key20180108003344_b39-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00210-008-0286-7","article-title":"Arginase and pulmonary diseases","volume":"378","author":"Maarsingh","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key20180108003344_b40-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200309-1304OC","article-title":"Decreased arginine bioavailability and increased serum arginase activity in asthma","volume":"170","author":"Morris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108003344_b41-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1183\/09031936.00057710","article-title":"Increased arginase activity contributes to airway remodelling in chronic allergic asthma","volume":"38","author":"Maarsingh","year":"2011","journal-title":"Eur Respir J"},{"key":"key20180108003344_b42-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.177.8.5595","article-title":"Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness","volume":"177","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"key20180108003344_b43-mmr-16-04-4151","doi-asserted-by":"crossref","first-page":"L911","DOI":"10.1152\/ajplung.00025.2009","article-title":"Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma","volume":"296","author":"North","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:03:32Z","timestamp":1750784612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,21]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7046"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7046","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"type":"print","value":"1791-2997"},{"type":"electronic","value":"1791-3004"}],"subject":[],"published":{"date-parts":[[2017,7,21]]}}}